Key Points
Patients had to take the drug within four days of showing COVID symptoms for it to be most effective...
A study published on June 8 in the medical journal The Lancet found that patientswho received metformin when they were first diagnosed with COVID-19 had a 41% reduced risk of developing long COVID 10 months later...
The study had limitations including that it was only tested on people with overweight or obesity but it showed promise forthe drug asa crucial tool in the fight against long COVID...
First, the study only tested the drug in people between the ages of 30-85 years old with overweight and obesity; we still don't know if metformin would work for different demographics.Second, the researchers said it was more effective if participants took the drug in fewer than four days after the onset of COVID symptoms, which may not be so easy in practice for many people..
Besides showing the benefits of metformin, the study may have had another inadvertent impact: Proving that long COVID does, in fact, exist, according to to Jeremy Faust, an emergency physician at Brigham and Women's Hospital...
You might be interested in
Cheap diabetes drug reduces long Covid risk by 40% after infection: Study
09, Jun, 23The study covered 1,126 overweight people in the United States, half receiving metformin and half a placebo in the days after testing positive for Covid.
Safe diabetes pill, metformin, reduces long Covid risk by 40 per cent, finds study
09, Jun, 23A two-week course of the safe, affordable diabetes medication, metformin, following a positive Covid test could reduce risk of long Covid by 40 per cent over the subsequent 10 months, a study published in The Lancet Infectious Diseases journal found.
US study finds 1 in 10 get long Covid after omicron, startidentifying key symptoms
09, Jun, 23About 10% of people appear to suffer long Covid after an omicron infection, a lower estimate than earlier in the pandemic, according to a study of nearly 10,000 Americans that aims to help unravel the mysterious condition.
People with long Covid respond differently to vaccines
04, May, 23After people with long Covid received the Covid-19 vaccine, they produced antibodies against SARS-CoV-2 virus for months longer than expected, according to a study.